NASDAQ: CDT
Conduit Pharmaceuticals Inc Stock

$2.33-0.14 (-5.67%)
Updated Jun 13, 2025
CDT Price
$2.33
Fair Value Price
N/A
Market Cap
$1.86M
52 Week Low
$2.31
52 Week High
$2,707.50
P/E
-0.01x
P/B
0.69x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$19.40M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.73
Operating Cash Flow
-$12M
Beta
-0.07
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CDT Overview

Murphy Canyon Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the construction/homebuilding companies and adjacent businesses targeting the real estate space. Murphy Canyon Acquisition was incorporated in 2021 and is headquartered in San Diego, CA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CDT's potential to beat the market

FStrong Sell
  • Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
CDT
Ranked
#440 of 464

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important CDT news, forecast changes, insider trades & much more!

CDT News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CDT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CDT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CDT is good value based on its book value relative to its share price (0.69x), compared to the US Biotechnology industry average (4.66x)
P/B vs Industry Valuation
CDT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CDT due diligence checks available for Premium users.

Valuation

CDT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.01x
Industry
-108.97x
Market
31.36x

CDT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.69x
Industry
4.66x
CDT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CDT's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.1M
Profit Margin
0%
CDT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$7.3M
Liabilities
$4.6M
Debt to equity
1.73
CDT's short-term assets ($5.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CDT's short-term assets ($5.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CDT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.3M
Investing
-$4.0k
Financing
$5.9M
CDT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CDT vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CDTF$1.86M-5.67%-0.01x0.69x
APVOD$1.78M-8.16%0.02x-1.21x
TNFA$1.94M-10.46%-0.02x0.22x
PTIXD$1.96M-5.68%-0.25x-22.14x
WINTF$2.17M-1.99%-0.00x0.21x

Conduit Pharmaceuticals Stock FAQ

What is Conduit Pharmaceuticals's quote symbol?

(NASDAQ: CDT) Conduit Pharmaceuticals trades on the NASDAQ under the ticker symbol CDT. Conduit Pharmaceuticals stock quotes can also be displayed as NASDAQ: CDT.

If you're new to stock investing, here's how to buy Conduit Pharmaceuticals stock.

What is the 52 week high and low for Conduit Pharmaceuticals (NASDAQ: CDT)?

(NASDAQ: CDT) Conduit Pharmaceuticals's 52-week high was $2,707.50, and its 52-week low was $2.31. It is currently -99.91% from its 52-week high and 0.87% from its 52-week low.

How much is Conduit Pharmaceuticals stock worth today?

(NASDAQ: CDT) Conduit Pharmaceuticals currently has 797,431 outstanding shares. With Conduit Pharmaceuticals stock trading at $2.33 per share, the total value of Conduit Pharmaceuticals stock (market capitalization) is $1.86M.

Conduit Pharmaceuticals stock was originally listed at a price of $15,044.99 in Feb 3, 2022. If you had invested in Conduit Pharmaceuticals stock at $15,044.99, your return over the last 3 years would have been -99.98%, for an annualized return of -94.63% (not including any dividends or dividend reinvestments).

How much is Conduit Pharmaceuticals's stock price per share?

(NASDAQ: CDT) Conduit Pharmaceuticals stock price per share is $2.33 today (as of Jun 13, 2025).

What is Conduit Pharmaceuticals's Market Cap?

(NASDAQ: CDT) Conduit Pharmaceuticals's market cap is $1.86M, as of Jun 14, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Conduit Pharmaceuticals's market cap is calculated by multiplying CDT's current stock price of $2.33 by CDT's total outstanding shares of 797,431.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.